Author

Wanqi Mi

Observed name: Mi, Wanqi

Institution: Harbin Medical University

Observed institution: Harbin Medical University

ORCID: 0000-0002-5263-1635

Observed ORCID: 0000-0002-5263-1635

OpenAlex ID: A5034334305

Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

2024 · Congxue Hu, Wanqi Mi, et al. · Scientific Data · 22

Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD

2023 · Jing Bai, Lun Zhu, et al. · Hepatology Communications · 12

Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis

2024 · Weilun Cheng, Wanqi Mi, et al. · Journal of Pharmaceutical Analysis · 10

PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients

2021 · Linan Xing, Songyu Tian, et al. · Frontiers in Cell and Developmental Biology · 9

PDF

Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization

2021 · Lin Cui, Ping Wang, et al. · Frontiers in Cell and Developmental Biology · 8

PDF

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data

2022 · Yanjun Xu, Jingwen Wang, et al. · Computational and Structural Biotechnology Journal · 6

PDF

Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma

2021 · Jingwen Wang, Feng Li, et al. · Journal of Translational Medicine · 6

PDF

The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis

2020 · Linan Xing, Wanqi Mi, et al. · Journal of Cellular and Molecular Medicine · 5

PDF

Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets

2022 · Congxue Hu, Yingqi Xu, et al. · Briefings in Bioinformatics · 4

Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma

2022 · Chunlong Zhang, Jiaxin Zhao, et al. · Journal of Translational Medicine · 4

PDF

Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts

2022 · Chunlong Zhang, Yuxi Zhang, et al. · Frontiers in Immunology · 3

Dissecting Melanoma Ecosystem Heterogeneity from Molecular Characteristics to Genetic Variation at Single-Cell Resolution

2025 · Congxue Hu, Liyuan Li, et al. · International Journal of Molecular Sciences · 1

Uncovering the Key Circuit FOSL2/FOS/EGR3/EGR1, Contributing to the Hyperexcitability of Excitatory Neurons in the Epileptic Temporal Cortex and Hippocampus

2026 · Jing Chen, Bowen Zhao, et al. · International Journal of Molecular Sciences

Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics

2026 · Tengyue Li, Wanqi Mi, et al. · GigaScience

PDF

Optimizing drug combination and detecting mechanism of drug combination based on pathway crosstalk in pan-cancer

2022 · Congxue Hu, Wanqi Mi, et al. · Research Square

PDF

MicrogliaST: a web server for microglia spatiotemportal pattern analysis in normal and disordered brains

2022 · Xiaoling Zhong, Feng Li, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Additional file 7 of Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma